CN Patent
CN104418834B — 一种抗糖尿病药物中间体的合成方法
Assigned to CHONGQING PORTON FINE CHEMICALS Co Ltd · Expires 2017-09-15 · 9y expired
What this patent protects
本发明公开了一种抗糖尿病药物中间体(式I)的合成方法,所述方法在于用式II化合物在特定还原剂的存在下,得到式I化合物。
USPTO Abstract
本发明公开了一种抗糖尿病药物中间体(式I)的合成方法,所述方法在于用式II化合物在特定还原剂的存在下,得到式I化合物。
Drugs covered by this patent
- Invokana (CANAGLIFLOZIN) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.